Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leandro Blas

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
International Journal of Urology : Official Journal of the Japanese Urological Association|December 28, 2023
Validation of schedules for optimal prostate-specific antigen monitoring after radical prostatectomyLeandro Blas, Masaki Shiota, Tokiyoshi Tanegashima, et al.
Journal of Robotic Surgery|August 27, 2023
Improved urinary continence recovery after robot-assisted radical prostatectomy with lateral pelvic fascia preservationMasaki Shiota, Shigehiro Tsukahara, Shohei Ueda, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 28, 2023
Bone-modifying agents are protective for symptomatic skeletal events in Radium-223 treatmentLeandro Blas, Masaki Shiota, Takashi Matsumoto, et al.
World Journal of Urology|October 30, 2024
Regression and growth rates in androgen deprivation therapy for advanced castration-sensitive prostate cancerLeandro Blas, Masaki Shiota, Hideyasu Matsuyama, et al.
Asian Journal of Endoscopic Surgery|January 11, 2024
Salvage robot-assisted radical prostatectomy after carbon ion radiotherapy to the prostateMasaki Shiota, Shigehiro Tsukahara, Dai Takamatsu, et al.
JMA Journal|May 25, 2022
External Validation of a Prognostic Model Predicting Metastatic Castration-Resistant Prostate Cancer Survival in Patients Receiving Post-Docetaxel Second-Line ChemotherapyLeandro Blas, Masaki Shiota, Motonobu Nakamura, et al.
Cancer Science|January 5, 2023
Genetic variations predicting progression with docetaxel and novel androgen-receptor pathway inhibitorsMasaki Shiota, Shusuke Akamatsu, Yuya Sekine, et al.
Anticancer Research|November 4, 2021
Prognostic Value of Lower Tract Urinary Symptoms in Clinically Regional Lymph Node-positive Prostate CancerLeandro Blas, Kosuke Ieiri, Masaki Shiota, et al.
Urologic Oncology|July 3, 2021
The impact of single-nucleotide polymorphisms on intravesical recurrence after bacillus Calmette-Guérin therapy for non-muscle invasive bladder cancer in a genome-wide association studyShohei Nagakawa, Masaki Shiota, Naohiro Fujimoto, et al.
JMA Journal|February 28, 2022
Anticancer Effect of Second-line Treatment for Castration-Resistant Prostate Cancer Following First-line Treatment with Androgen Receptor Pathway InhibitorsTakashi Matsumoto, Masaki Shiota, Shigetomo Yamada, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
International Journal of Urology : Official Journal of the Japanese Urological Association|December 28, 2023
Validation of schedules for optimal prostate-specific antigen monitoring after radical prostatectomyLeandro Blas, Masaki Shiota, Tokiyoshi Tanegashima, et al.
Journal of Robotic Surgery|August 27, 2023
Improved urinary continence recovery after robot-assisted radical prostatectomy with lateral pelvic fascia preservationMasaki Shiota, Shigehiro Tsukahara, Shohei Ueda, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 28, 2023
Bone-modifying agents are protective for symptomatic skeletal events in Radium-223 treatmentLeandro Blas, Masaki Shiota, Takashi Matsumoto, et al.
World Journal of Urology|October 30, 2024
Regression and growth rates in androgen deprivation therapy for advanced castration-sensitive prostate cancerLeandro Blas, Masaki Shiota, Hideyasu Matsuyama, et al.
Asian Journal of Endoscopic Surgery|January 11, 2024
Salvage robot-assisted radical prostatectomy after carbon ion radiotherapy to the prostateMasaki Shiota, Shigehiro Tsukahara, Dai Takamatsu, et al.
JMA Journal|May 25, 2022
External Validation of a Prognostic Model Predicting Metastatic Castration-Resistant Prostate Cancer Survival in Patients Receiving Post-Docetaxel Second-Line ChemotherapyLeandro Blas, Masaki Shiota, Motonobu Nakamura, et al.
Cancer Science|January 5, 2023
Genetic variations predicting progression with docetaxel and novel androgen-receptor pathway inhibitorsMasaki Shiota, Shusuke Akamatsu, Yuya Sekine, et al.
Anticancer Research|November 4, 2021
Prognostic Value of Lower Tract Urinary Symptoms in Clinically Regional Lymph Node-positive Prostate CancerLeandro Blas, Kosuke Ieiri, Masaki Shiota, et al.
Urologic Oncology|July 3, 2021
The impact of single-nucleotide polymorphisms on intravesical recurrence after bacillus Calmette-Guérin therapy for non-muscle invasive bladder cancer in a genome-wide association studyShohei Nagakawa, Masaki Shiota, Naohiro Fujimoto, et al.
JMA Journal|February 28, 2022
Anticancer Effect of Second-line Treatment for Castration-Resistant Prostate Cancer Following First-line Treatment with Androgen Receptor Pathway InhibitorsTakashi Matsumoto, Masaki Shiota, Shigetomo Yamada, et al.
Pageof 8